Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
44,559
Total Value
$535,880.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 14,853 | $10.42 | $154,768.26 | 14,853 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jun 1, 2026 | Sale | 13,253 | $25.57 | $338,940.17 | 1,600 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jun 1, 2026 | Sale | 1,600 | $26.36 | $42,172.16 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 14,853 | $0.00 | $0.00 | 207,554 | Direct | โ | View Details |